It seems like they had quite a few. primary outcomes. Did they do any correcting for multiple tests? I didn't see it.
Also, can someone explain to me the difference between the ANCOVA findings on the primary outcomes, and the mixed models for repeated measures (MMRM) results? They seem to get different results on those for the PHQ-15 on somatic symptoms--there's no difference in the primary analysis but there is a difference in the MMRM analysis, which was part of sensitivity analysis but is what they mention in the abstract. Also, they refer to the MMRM results as "post-hoc," which I also don't understand.
